Marshall Wace’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-55,646
| Closed | -$83.5K | – | 2268 |
|
|
2023
Q1 | $83.5K | Buy |
55,646
+18,528
| +50% | +$27.8K | ﹤0.01% | 2013 |
|
|
2022
Q4 | $43.4K | Sell |
37,118
-6,709
| -15% | -$7.85K | ﹤0.01% | 2241 |
|
|
2022
Q3 | $50K | Buy |
+43,827
| New | +$50K | ﹤0.01% | 2461 |
|
|
2021
Q3 | – | Sell |
-186,940
| Closed | -$533K | – | 2639 |
|
|
2021
Q2 | $533K | Buy |
+186,940
| New | +$533K | ﹤0.01% | 1643 |
|